Bradley J. Bolzon Ph.D., Director at CRISPR Therapeutics AG (CRSP), sold 710,079 shares at $152.42 ($14.1M) on 2021-06-29, disclosed to the SEC on 2021-06-30.
Open-market sale of $14.1M CRSP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 615,607 | $0 | 0.0% |
| 2 | $145.92 | 1,400 | $204K | 1.4% |
| 3 | $145.92 | 1,400 | $204K | 1.4% |
| 4 | $146.69 | 600 | $88K | 0.6% |
| 5 | $147.43 | 4,780 | $705K | 5.0% |
| 6 | $147.43 | 4,780 |
| $705K |
| 5.0% |
| 7 | $148.58 | 12,176 | $1.8M | 12.8% |
| 8 | $148.58 | 12,176 | $1.8M | 12.8% |
| 9 | $149.47 | 7,981 | $1.2M | 8.4% |
| 10 | $149.47 | 7,981 | $1.2M | 8.4% |
| 11 | $150.49 | 12,753 | $1.9M | 13.6% |
| 12 | $150.49 | 12,753 | $1.9M | 13.6% |
| 13 | $151.24 | 6,646 | $1.0M | 7.1% |
| 14 | $151.24 | 6,646 | $1.0M | 7.1% |
| 15 | $152.42 | 1,200 | $183K | 1.3% |
| 16 | $152.42 | 1,200 | $183K | 1.3% |
| Total | $19.89 avg | 710,079 | $14.1M | 100% |
| Filing → |
| CRSP | SELL | 2021-06-30 | $9.2M | — | Filing → |
| CRSP | SELL | 2021-06-15 | $2.3M | — | Filing → |
| CRSP | SELL | 2021-03-24 | $8.0M | — | Filing → |